Letter to the editor from Pant et al

Shubham Pant; Justin T. Moyers; Aung Naing

doi:10.1136/jitc-2021-003991

Letter to the editor from Pant et al

Shubham Pant, Justin T. Moyers, Aung Naing

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e003991
Journal	Journal for immunotherapy of cancer
Volume	9
Issue number	11
DOIs	https://doi.org/10.1136/jitc-2021-003991
State	Published - Nov 1 2021

Keywords

clinical trials
immunotherapy
phase II as topic

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Molecular Medicine
Oncology
Pharmacology
Cancer Research

Access to Document

10.1136/jitc-2021-003991

Cite this

@article{471db9909692450a87a6f0c790243d5f,

title = "Letter to the editor from Pant et al",

keywords = "clinical trials, immunotherapy, phase II as topic",

author = "Shubham Pant and Moyers, {Justin T.} and Aung Naing",

year = "2021",

month = nov,

day = "1",

doi = "10.1136/jitc-2021-003991",

language = "English (US)",

volume = "9",

journal = "Journal for immunotherapy of cancer",

issn = "2051-1426",

publisher = "BioMed Central",

number = "11",

}

TY - JOUR

T1 - Letter to the editor from Pant et al

AU - Pant, Shubham

AU - Moyers, Justin T.

AU - Naing, Aung

PY - 2021/11/1

Y1 - 2021/11/1

KW - clinical trials

KW - immunotherapy

KW - phase II as topic

UR - http://www.scopus.com/inward/record.url?scp=85118931607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118931607&partnerID=8YFLogxK

U2 - 10.1136/jitc-2021-003991

DO - 10.1136/jitc-2021-003991

M3 - Letter

C2 - 34725215

AN - SCOPUS:85118931607

SN - 2051-1426

VL - 9

JO - Journal for immunotherapy of cancer

JF - Journal for immunotherapy of cancer

IS - 11

M1 - e003991

ER -

Letter to the editor from Pant et al

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this